Clinical trial
Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease
NCT02110303 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- April 30, 2018
- Enrollment
- 220 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.